인공 각막 및 각막 임플란트 시장 규모, 점유율, 동향, 예측 : 유형, 이식 유형, 질환 적응증, 최종사용자, 지역별(2025-2033년)

The global artificial cornea and corneal implant market size was valued at USD 468.85 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 831.98 Million by 2033, exhibiting a CAGR of 6.25% during 2025-2033. North America currently dominates the market with a market share of 50.5%. The growing prevalence of corneal infections and eye-associated disorders, rising construction of various healthcare facilities, and escalating demand for full-thickness corneal transplantation represent some of the key factors driving the market.

Artificial cornea and corneal implant refer to specific surgical procedures conducted to replace segments of the damaged cornea with healthy and unaffected corneal tissue obtained from a donor. They consist of a wide variety of medical procedures, such as penetrating and endothelial keratoplasty, which involves the transplantation of the entire corneal stem cells. They involve transplantation of implants that are hydrogels in nature and manufactured with recombinant collagen and inserted in a tiny incision made on the cornea of the patient. These procedures are primarily performed for the treatment of infectious keratitis, keratoconus, corneal ulcers, and Fuchs dystrophy diseases. Artificial cornea and corneal implant are also necessary for curing anterior corneal pathologies, such as trachoma, infectious keratitis, ocular trauma, and chemical injuries. They help improve eyesight, relieve pain, maintain the proper shape of the cornea, and treat severe infections or damage. They also assist in restoring a clear vision of patients suffering from corneal scarring and corneal diseases and enable them to perform daily activities effortlessly.

Artificial Cornea and Corneal Implant Market Trends:

At present, the increasing demand for artificial cornea and corneal implants due to the rising prevalence of corneal infections and eye-associated disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing construction of various healthcare facilities, such as hospitals, nursing homes, and eye clinics, to provide effective treatment to patients is offering a favorable market outlook. In addition, the rising occurrence of eyesight complications among young individuals for spending prolonged hours looking at smartphones or working on computers and laptops is propelling the growth of the market. Apart from this, the increasing demand for full-thickness corneal transplantation due to the rising geriatric population worldwide is contributing to the growth of the market. Additionally, there is a rise in the adoption of minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays. This, coupled with the increasing preference for penetrating keratoplasty procedures to treat eye-related complications in older patients, is supporting the market growth. Moreover, the rising utilization of various innovative and effective medical products, such as three-dimensional (3D) printed artificial cornea with better biocompatibility and customizability in treating corneal diseases, is strengthening the market growth.

Key Market Segmentation:

Type Insights:

• Human Cornea
• Artificial Cornea

Transplant Type Insights:

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior Lamellar Keratoplasty
• Keratoprosthesis

Disease Indication Insights:

• Fuchs' Dystrophy
• Fungal Keratitis
• Keratoconus
• Others

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for artificial cornea and corneal implant. Some of the factors driving the North America artificial cornea and corneal implant market included the aging population, rising advancements in eye care treatment procedures, improving healthcare expenditure, etc.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global artificial cornea and corneal implant market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC, San Diego Eye Bank, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1.What are artificial cornea and corneal implants?
• 2.How big is the artificial cornea and corneal implant market?
• 3.What is the expected growth rate of the global artificial cornea and corneal implant market during 2025-2033?
• 4.What are the key factors driving the global artificial cornea and corneal implant market?
• 5.What is the leading segment of the global artificial cornea and corneal implant market based on the type?
• 6.What is the leading segment of the global artificial cornea and corneal implant market based on the transplant type?
• 7.What is the leading segment of the global artificial cornea and corneal implant market based on the disease indication?
• 8.What is the leading segment of the global artificial cornea and corneal implant market based on the end user?
• 9.What are the key regions in the global artificial cornea and corneal implant market?
• 10.Who are the key players/companies in the global artificial cornea and corneal implant market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Artificial Cornea and Corneal Implant Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Human Cornea
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Artificial Cornea
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Transplant Type

• 7.1 Penetrating Keratoplasty
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Endothelial Keratoplasty
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Anterior Lamellar Keratoplasty
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Keratoprosthesis
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Disease Indication

• 8.1 Fuchs' Dystrophy
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Fungal Keratitis
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Keratoconus
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Specialty Clinics
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Advancing Sight Network
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 AJL Ophthalmic S.A.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Aurolab
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Corneat Vision Ltd
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 EyeYon Medical
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Florida Lions Eye Bank
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Keramed Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 L V Prasad Eye Institute
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 LinkoCare Life Sciences AB
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Mediphacos
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Presbia PLC
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 San Diego Eye Bank
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio